Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

Weight-loss jabs have been hailed as the key to longer life even if you are not overweight, according to experts.

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

Cipla’s Q4FY25 revenue rose 9% year-on-year to ₹6,730 crore, while it reported profit after tax of ₹1,222 crore, up 30% from ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

Most Britons could soon use weight loss jabs to live longer, Britain’s most eminent medic has said. Experts hailed a “golden age” in obesity treatment thanks to drugs which have been found to halve ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...